DermTopic: Fillers and Injectables

Filter Your Results




Recent Developments

SK Breakthrough: FDA Approves Eskata Topical Solution from Aclaris The FDA has approved Eskata (hydrogen peroxide) to…

Therapeutics Update: Notable Approvals in 2017

One of the most widely anticipated approvals in 2017 was for Dupixent (dupilumab, Regeneron Pharmaceuticals, Inc.) injec…

Following Autoimmune Diseases Through Patient Interactive Di…

Autoimmune diseases (AID) usually generate autoantibodies that can cause immune complex driven tissue inflammation and e…

Katelyn M. Updyke, BS; Brittany Urso, BS; Haider Ali, BS; Ian Brooks, PhD; Vernon Burton, PhD; Robert P. Dellavalle, MD, PhD, MSPH; and James A. Solomon, MD, PhD


img class="left" src="" sty

Revance: RT002 Achieves 6-Month Duration in Phase 3

  Revance Therapeutics’ next-generation neuromodulator DaxibotulinumtoxinA for Injection (RT002) delivered…

9th Annual Cosmetic Surgery Forum Kicks Off in Las Vegas

Cosmetic Surgery Forum 2017, now in its ninth year, got underway with a Director’s Welcome Reception on Wedne…

Eliminating the Fear Factor with Novel Neuromodulators

The neuromodulator category is not quite as evolved as the filler category -- yet. There are currently three botulinum T…

Denise Mann, Editor-at-Large

Prescriber, Beware: Understanding and Protecting Drug Compou…

Imagine a dermatology office where aluminum chloride, arguably the most commonly used hemostatic agent in dermatology cl…

Paul Winnington, Editorial Director


Contact Info

For advertising rates and opportunities:
Ali Kinnie
(917) 589-4160

Rick Ehrlich
Associate Publisher
(609) 922-0337

About Practical Dermatology

Practical Dermatology is the monthly publication that provides coverage of medical care, cosmetic advancements, and practice management for clinicians in the field. With straight-forward, how-to advice from experts in various fields, we strive to enhance quality of care and improve the daily operation of dermatology practices.